The orbital tissue expander market is projected to grow from USD 577.1 million in 2025 to USD 940.0 million by 2035, at a CAGR of 5.0%. Hydrophilic osmotic hydrogel devices will dominate with a 58.3% market share, while hospitals will lead the distribution channel segment with a 46.7% share.